Dare Bioscience Inc expected to post breakeven results a share - Earnings Preview

Dare Bioscience

10/08/2024 24:55

* Dare Bioscience Inc  DARE.OQ   DARE.O  is expected to show
a
rise in quarterly revenue when it reports  results on August 12
for the period ending June 30 2024
    * The San Diego California-based  company is expected to
report
revenue of $5.892 million, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Dare Bioscience Inc is
for
breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $48.00​, above​ its last closing price of $3.39. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.72       -0.72      -0.84     Missed  -16.7
 Dec. 31 2024  -1.60       -1.18      -0.72     Beat    38.8
 Sep. 30 2023  -1.16       -1.18      -1.08     Beat    8.2​
 Jun. 30 2023  -1.21       -1.18      -1.20     Missed  -1.7
 ​​Mar.        -1.22       -1.20      -1.08     Beat    10
 31 2023                                                
 Dec. 31 2022  -1.62       -1.64      -2.28     Missed  -39​
 Sep. 30 2022  -1.35       -1.41      -0.96     Beat    31.9
 Jun. 30 2022  -0.76       -0.76      0.00      Beat    100
 This summary was machine generated August 9 at 23:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)